The Atypical Cannabinoid Abn-CBD Reduces Inflammation and Protects Liver, Pancreas, and Adipose Tissue in a Mouse Model of Prediabetes and Non-alcoholic Fatty Liver Disease.

Romero-Zerbo, Silvana Y

The Atypical Cannabinoid Abn-CBD Reduces Inflammation and Protects Liver, Pancreas, and Adipose Tissue in a Mouse Model of Prediabetes and Non-alcoholic Fatty Liver Disease. [electronic resource] - Frontiers in endocrinology 2020 - 103 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1664-2392

10.3389/fendo.2020.00103 doi


Adipose Tissue--drug effects
Animals
Cytoprotection--drug effects
Diet, High-Fat
Disease Models, Animal
Inflammation--etiology
Liver--drug effects
Male
Mice
Mice, Inbred C57BL
Mice, Obese
Non-alcoholic Fatty Liver Disease--drug therapy
Obesity--complications
Pancreas--drug effects
Prediabetic State--drug therapy
Resorcinols--pharmacology